Roche has returned the rights to UCB’s anti-tau antibody bepranemab, walking away from a $120 million bet on the Alzheimer’s ...

United Community Banks ( (UCB) ) has shared an announcement. United Community Banks, Inc. reported a net income of $47.3 ...

United Community Banks, Inc. (NYSE:UCB) Q3 2024 Earnings Call Transcript October 23, 2024 Operator: Good morning and welcome to United Community Bank's Third Quarter 2024 Earnings Call. Hosting the ...

UCB today announced that the company has regained all global rights to bepranemab following termination of a collaboration ...

UCB SA has a promising drug, Bimzelx, despite temporary EBITDA decline and potential regulatory hurdles ahead. Learn more ...

For the quarter ended September 2024, United Community Banks (UCB) reported revenue of $244.49 million, up 4.3% over the same period last year. EPS came in at $0.57, compared to $0.45 in the year-ago ...

Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...

UCB recently hosted the orientation programme for this year’s third intake of the Monash College Diploma programme.

United Community Banks Inc (NYSE:UCB) is set to release its Q3 2024 earnings on Oct 23, 2024. The consensus estimate for Q3 ...

GREENVILLE, S.C. , Oct. 23, 2024 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) (United) today announced net income for the 2024 third quarter of $47.3 million and pre-tax, pre-provision ...

October 17, 2024, 13:48 pm ET, BY Jolene W.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) Short UCB slightly ...

Good morning and welcome to United Community Bank's Third Quarter 2024 Earnings Call. Hosting the call today are Chairman and Chief Executive Officer Lynn Harton, Chief Financial Officer Jefferson ...